Unbiased AI-powered news
2 stories related to this topic, newest first.
thenation.comA 44-year-old professional tennis player returned to competition after nearly four years away and disclosed use of a GLP-1 weight-loss drug. The player won an opening doubles match at one tournament but lost the next. Sports officials are monitoring whether such medications affec…
nypost.comA study published Monday in JAMA Network Open documented a sharp increase in leucovorin prescriptions. The rise followed media coverage and a September 2025 White House statement describing the drug as an autism treatment. Leucovorin is approved for cerebral folate deficiency but…